Drug intelligence / Profile preview

dexamethasone isonicotinate

Development stage
Approved
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Inhalation, Topical, Parenteral
01

Overview

Dexamethasone isonicotinate is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and anti-allergic properties. It can be administered orally, by inhalation, topically, or parenterally. The drug acts primarily by binding to the cytoplasmic glucocorticoid receptor, leading to suppression of immune responses and reduction of inflammation through changes in gene expression. Dexamethasone isonicotinate may also exhibit unintended mineralocorticoid activity, potentially causing salt and water retention. It has veterinary uses for controlling central nervous system inflammation in animals such as dogs and cats, as well as for treating primary bovine ketosis in cattle[1][2][7][8].

Brand names
Alin DepotAuxilosonAuxilsonAuxilsoneVoren
Other names
dexamethasone-21-isonicotinatedexamethasone21-isonicotinatedexamethasone 21-isonicotinate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone isonicotinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone isonicotinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call